An Open-label, Multicenter, Multiple Dose, Phase 1 Study to Establish the Maximum Tolerated Dose of E7389 Liposomal Formulation in Patients With Solid Tumors
Clinical trial NCT01945710 · COMPLETED
Trial details
- NCT number
- NCT01945710
- Sponsor
- Eisai Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-11
- Primary completion
- 2015-10-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.